Glioma
|
0.320 |
GeneticVariation
|
disease |
BEFREE |
Mutations in the critical chromatin modifier ATRX and mutations in CIC and FUBP1, which are potent regulators of cell growth, have been discovered in specific subtypes of gliomas, the most common type of primary malignant brain tumors.
|
22869205 |
2012 |
Neoplasms
|
0.100 |
GeneticVariation
|
group |
BEFREE |
One of these tumors also had a deleterious mutation in FUBP1.
|
24086756 |
2013 |
Neoplasms
|
0.100 |
GeneticVariation
|
group |
BEFREE |
Among other changes, we found that the CIC gene (homolog of the Drosophila gene capicua) on chromosome 19q was somatically mutated in six cases and that the FUBP1 gene [encoding far-upstream element (FUSE) binding protein] on chromosome 1p was somatically mutated in two tumors.
|
21817013 |
2011 |
oligodendroglioma
|
0.080 |
GeneticVariation
|
disease |
BEFREE |
CIC and FUBP1 mutations occurred frequently in oligodendrogliomas (46% and 24%, respectively) but rarely in astrocytomas or oligoastrocytomas ( more than 10%).
|
22869205 |
2012 |
oligodendroglioma
|
0.080 |
GeneticVariation
|
disease |
BEFREE |
The meeting consisted of 3 scientific sessions ranging from neuropathology of IDH1 mutations; CIC, ATRX, and FUBP1 mutations in oligodendrogliomas and astrocytomas; and IDH1 mutations as therapeutic targets.
|
23373454 |
2013 |
oligodendroglioma
|
0.080 |
GeneticVariation
|
disease |
BEFREE |
Using this approach, we detected a to-date undescribed FUBP1 mutation in an oligodendroglioma.
|
24117486 |
2014 |
oligodendroglioma
|
0.080 |
GeneticVariation
|
disease |
BEFREE |
Causal genetic changes in oligodendrogliomas (OD) with 1p/19q co-deletion include mutations in IDH1, IDH2, CIC, FUBP1, TERT promoter and NOTCH1.
|
25694352 |
2015 |
oligodendroglioma
|
0.080 |
GeneticVariation
|
disease |
BEFREE |
Our data confirm CIC and FUBP1 mutations in oligodendrogliomas and demonstrate the presence of these mutations in oligoastrocytomas.
|
22588899 |
2012 |
oligodendroglioma
|
0.080 |
GeneticVariation
|
disease |
BEFREE |
Next-generation molecular biology technologies have recently identified recurrent CIC and FUBP1 point mutations in 1p/19q codeleted and IDH-mutated oligodendrogliomas.
|
22913971 |
2012 |
oligodendroglioma
|
0.080 |
GeneticVariation
|
disease |
BEFREE |
Examination of 27 additional oligodendrogliomas revealed 12 and 3 more tumors with mutations of CIC and FUBP1, respectively, 58% of which were predicted to result in truncations of the encoded proteins.
|
21817013 |
2011 |
Well Differentiated Oligodendroglioma
|
0.080 |
GeneticVariation
|
disease |
BEFREE |
Our data confirm CIC and FUBP1 mutations in oligodendrogliomas and demonstrate the presence of these mutations in oligoastrocytomas.
|
22588899 |
2012 |
Well Differentiated Oligodendroglioma
|
0.080 |
GeneticVariation
|
disease |
BEFREE |
Using this approach, we detected a to-date undescribed FUBP1 mutation in an oligodendroglioma.
|
24117486 |
2014 |
Well Differentiated Oligodendroglioma
|
0.080 |
GeneticVariation
|
disease |
BEFREE |
Causal genetic changes in oligodendrogliomas (OD) with 1p/19q co-deletion include mutations in IDH1, IDH2, CIC, FUBP1, TERT promoter and NOTCH1.
|
25694352 |
2015 |
Well Differentiated Oligodendroglioma
|
0.080 |
GeneticVariation
|
disease |
BEFREE |
Examination of 27 additional oligodendrogliomas revealed 12 and 3 more tumors with mutations of CIC and FUBP1, respectively, 58% of which were predicted to result in truncations of the encoded proteins.
|
21817013 |
2011 |
Well Differentiated Oligodendroglioma
|
0.080 |
GeneticVariation
|
disease |
BEFREE |
Next-generation molecular biology technologies have recently identified recurrent CIC and FUBP1 point mutations in 1p/19q codeleted and IDH-mutated oligodendrogliomas.
|
22913971 |
2012 |
Well Differentiated Oligodendroglioma
|
0.080 |
GeneticVariation
|
disease |
BEFREE |
The meeting consisted of 3 scientific sessions ranging from neuropathology of IDH1 mutations; CIC, ATRX, and FUBP1 mutations in oligodendrogliomas and astrocytomas; and IDH1 mutations as therapeutic targets.
|
23373454 |
2013 |
Well Differentiated Oligodendroglioma
|
0.080 |
GeneticVariation
|
disease |
BEFREE |
CIC and FUBP1 mutations occurred frequently in oligodendrogliomas (46% and 24%, respectively) but rarely in astrocytomas or oligoastrocytomas ( more than 10%).
|
22869205 |
2012 |
Adult Oligodendroglioma
|
0.030 |
GeneticVariation
|
disease |
BEFREE |
Mutations in CIC and FUBP1 contribute to human oligodendroglioma.
|
21817013 |
2011 |
Adult Oligodendroglioma
|
0.030 |
GeneticVariation
|
disease |
BEFREE |
Using this approach, we detected a to-date undescribed FUBP1 mutation in an oligodendroglioma.
|
24117486 |
2014 |
Childhood Oligodendroglioma
|
0.030 |
GeneticVariation
|
disease |
BEFREE |
Using this approach, we detected a to-date undescribed FUBP1 mutation in an oligodendroglioma.
|
24117486 |
2014 |
Childhood Oligodendroglioma
|
0.030 |
GeneticVariation
|
disease |
BEFREE |
Mutations in CIC and FUBP1 contribute to human oligodendroglioma.
|
21817013 |
2011 |
Anaplastic Oligodendroglioma
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
These findings confirm that IDH, CIC, FUBP1 mutations and rs55705857 genotype are common in AO.
|
28388591 |
2017 |
Anemia, Hemolytic
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
We have identified a new mutation in the FBP (fructose 1,6-bisphosphate) aldolase A gene in a child with suspected haemolytic anaemia associated with myopathic symptoms at birth and with a subsequent diagnosis of arthrogryposis multiplex congenita and pituitary ectopia.
|
14766013 |
2004 |
Arthrogryposis
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
We have identified a new mutation in the FBP (fructose 1,6-bisphosphate) aldolase A gene in a child with suspected haemolytic anaemia associated with myopathic symptoms at birth and with a subsequent diagnosis of arthrogryposis multiplex congenita and pituitary ectopia.
|
14766013 |
2004 |
Astrocytoma
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
CIC and FUBP1 mutations occurred frequently in oligodendrogliomas (46% and 24%, respectively) but rarely in astrocytomas or oligoastrocytomas ( more than 10%).
|
22869205 |
2012 |